Chemkart India Limited has made an investment of ₹10.00 lakh in its wholly-owned subsidiary Vinstar Biotech Private Limited through a rights issue. The investment was made by way of issue and allotment of 1,00,000 equity shares of face value ₹10 each at an issue price of ₹10 per share (at face value).
Subsidiary Company Details
- Name: Vinstar Biotech Private Limited
- Authorized Share Capital: ₹15,00,000 divided into 1,50,000 equity shares of ₹10 each
- Paid-up Share Capital (Post Allotment): ₹11,00,000 divided into 1,10,000 equity shares of ₹10 each
- Financial Performance (as of 31st March 2026):
- Turnover: ₹223.43 lakh
- Loss after Tax: Negative ₹(24.72) lakh
- Net Worth: Negative ₹(34.69) lakh
- Business Description: R&D-driven nutraceutical company specializing in proprietary bioactive technologies and commercial distribution of health and nutraceutical products, focusing on liposomal and microencapsulated delivery platforms
- Incorporation: 2023 (India)
- Historical Turnover:
- FY 2023-24: Nil
- FY 2024-25: Nil
- FY 2025-26: ₹223.43 lakh
Transaction Details
- Investment Amount: ₹10.00 lakh
- Shares Allotted: 1,00,000 equity shares of ₹10 each at face value
- Consideration Type: Cash consideration
- Shareholding Pattern:
- Pre-allotment: 100.00%
- Post-allotment: 100.00%
- Transaction Nature: Related party transaction (as wholly-owned subsidiary) conducted at arm's length
- Purpose: Working capital requirements